NYSE · Healthcare
MCKESSON CORP (MCK)
As-reported financials and recent SEC filings for MCKESSON CORP, latest fiscal period FY2026. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$403.43B
Net income
$4.76B
Net margin
1.2%
Diluted EPS
$38.38
ROE
-268.0%
P/E (TTM)
20.4×
Market cap
$94.25B
Debt / equity
-3.0×
Income statement (as reported)
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $403.43B | $359.05B | $308.95B | $276.71B | $263.97B |
| Gross profit | $14.55B | $13.32B | $12.83B | $12.36B | $13.13B |
| Operating income | $6.21B | $4.42B | $3.91B | $4.38B | $2.04B |
| Net income | $4.76B | $3.29B | $3.00B | $3.56B | $1.11B |
| Diluted EPS | $38.38 | $25.72 | $22.39 | $25.03 | $7.23 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
1442026-06-09
View on EDGAR →42026-06-08
View on EDGAR →42026-06-03
View on EDGAR →1442026-06-02
View on EDGAR →42026-06-02
View on EDGAR →1442026-06-01
View on EDGAR →1442026-06-01
View on EDGAR →42026-06-01
View on EDGAR →Go deeper on MCK
Search MCKESSON CORP’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.